|Bid||0.4950 x 0|
|Ask||0.5000 x 0|
|Day's Range||0.4950 - 0.5000|
|52 Week Range||0.4200 - 0.8700|
|Beta (5Y Monthly)||0.19|
|PE Ratio (TTM)||24.75|
|Earnings Date||Dec 21, 2022 - Dec 28, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Sept 02, 1999|
|1y Target Est||1.13|
Announces that, on behalf of Santina Castriciano of Copan Italia S.p.A. and in collaboration with Victorian ...
Microbix Biosystems' (TSE:MBX) stock is up by 4.1% over the past three months. Given its impressive performance, we...
MSwab® & PROCEEDx™FLOQ® Supporting Self-Collection for HPV Screening ProgramsMISSISSAUGA, Ontario, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that, on behalf of Santina Castriciano of Copan Italia S.p.A. and in collaboration with Victorian Cytology Service of the Australian Centre for the Prevention of Cervical Cancer (VCS Pathology), it will present results of novel methods to s